Carmell Therapeutics Corporation (CTCX)

NASDAQ: CTCX · IEX Real-Time Price · USD

2.010

-0.190 (-8.64%)

At close: Apr 24, 2024, 3:33 PM

2.000

-0.010 (-0.50%)

After-hours: Apr 24, 2024, 4:58 PM EDT

Carmell Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Net Income	-16.12	-9.61	-6.79
Depreciation & Amortization	0.12	0.24	0.24
Share-Based Compensation	0.67	0.64	0.25
Other Operating Activities	6.3	4.74	4.81
Operating Cash Flow	-8.35	-3.43	-1.18
Capital Expenditures	-0.03	-0.01	-0.01
Investing Cash Flow	-0.03	-0.01	-0.01
Share Issuance / Repurchase	30.99	-0	0.24
Debt Issued / Paid	-1.34	2.36	1.12
Other Financing Activities	-18.49	1.19	-0.17
Financing Cash Flow	11.16	3.55	1.2
Net Cash Flow	2.78	0.12	0.01
Free Cash Flow	-8.38	-3.44	-1.18
Free Cash Flow Per Share	-0.76	-1.96	-0.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).